ABVC BioPharma
ABVCABVC BioPharma, Inc. (NASDAQ: ABVC) is a clinical-stage biopharmaceutical company based in the United States. Its business focus is the development of novel therapeutic products, with its pipeline targeting medical needs in oncology/hematology, neurology, and ophthalmology. The company's research and development strategy involves both botanical-derived compounds and synthetic molecules. The company's clinical-stage assets include treatments for conditions such as Major Depressive Disorder (MDD) and Attention-Deficit/Hyperactivity Disorder (ADHD). In oncology, its development programs address conditions like non-small cell lung cancer and pancreatic cancer. ABVC BioPharma operates through its own research and development efforts and via collaborations with academic and medical institutions to advance its candidates through clinical trials. As a publicly traded entity, ABVC BioPharma's operations and financial position are documented in its filings with the U.S. Securities and Exchange Commission. The company's activities are centered on progressing its drug candidates through the regulatory development pathway required for potential market approval.
ABVC · Stock Price
Historical price data
About
ABVC BioPharma, Inc. (NASDAQ: ABVC) is a clinical-stage biopharmaceutical company based in the United States. Its business focus is the development of novel therapeutic products, with its pipeline targeting medical needs in oncology/hematology, neurology, and ophthalmology. The company's research and development strategy involves both botanical-derived compounds and synthetic molecules. The company's clinical-stage assets include treatments for conditions such as Major Depressive Disorder (MDD) and Attention-Deficit/Hyperactivity Disorder (ADHD). In oncology, its development programs address conditions like non-small cell lung cancer and pancreatic cancer. ABVC BioPharma operates through its own research and development efforts and via collaborations with academic and medical institutions to advance its candidates through clinical trials. As a publicly traded entity, ABVC BioPharma's operations and financial position are documented in its filings with the U.S. Securities and Exchange Commission. The company's activities are centered on progressing its drug candidates through the regulatory development pathway required for potential market approval.